Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Primary Peptides logo — Creating New Therapeutics through Protein Manipulation.

Primary Peptides

Creating New Therapeutics through Protein Manipulation.

Founded 2013 Canada Canada 6 employees

General Information

Company Name Primary Peptides
Founded Year 2013
Location Canada Canada +1
Employees 6
Social

Get notified when Primary Peptides moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Primary Peptides

We are a clinical stage protein manipulation company creating new therapeutics for patients worldwide. Our platform technologies consist of: - Protein-protein interaction blockade which prevents specific disease-causing proteins from interacting with each other; - Protein degradation which harnesses the body's own natural processes to destroy disease causing proteins. By adopting these approaches, we are expanding the scope of new targets for drug development and unlocking the untapped pool of targets that to date have been considered undruggable. Our goal is to develop a new generation of therapeutics for patients that currently have few options, if any, to treat their diseases effectively.

No funding data available for Primary Peptides yet.

Get notified when Primary Peptides raises funding

Primary Peptides Alternatives & Competitors

Primary Peptides vs
TRIANA Biomedicines
TRIANA Biomedicines

A venture-backed biopharmaceutical company dedicated to discovering and developing novel therapeutic...

Primary Peptides vs
Lycia Therapeutics
Lycia Therapeutics United States

Building the leading extracellular protein degradation company

38 employees
Primary Peptides vs
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. United States

Clinical-stage biotech company transforming how disease is treated through targeted protein degradat...

IPO
111 employees
Biotechnology, Health Care

FAQ About Primary Peptides

Creating New Therapeutics through Protein Manipulation.
Primary Peptides was founded in 2013.
Primary Peptides is headquartered in Canada.
Primary Peptides has approximately 6 employees.
Top alternatives and competitors to Primary Peptides include TRIANA Biomedicines, Lycia Therapeutics, C4 Therapeutics, Inc., SEED Therapeutics, Cullgen Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Primary Peptides and TRIANA Biomedicines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Primary Peptides and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy